| This goes against NHS England and DH focus on high quality care, it argues Related items from OnMedica Hormone therapy treatment helps treat type 2 diabetes well Long-acting GLP-1 agonists for type 2 diabetes Are industry ‘supertrialists’ imbalancing diabetes research? Safety review launched into diabetic drugs |
Monday, 27 July 2015
Draft diabetes guidance too heavily focused on cost, protests industry
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment